| Product Code: ETC7051990 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Oncology-Cancer Drugs Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 Egypt Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 Egypt Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Egypt Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Egypt Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Egypt |
4.2.2 Growing awareness about cancer treatment options |
4.2.3 Technological advancements in oncology drugs development |
4.3 Market Restraints |
4.3.1 High cost of oncology-cancer drugs |
4.3.2 Limited access to advanced cancer treatment facilities in certain regions of Egypt |
4.3.3 Stringent regulatory requirements for drug approval |
5 Egypt Oncology-Cancer Drugs Market Trends |
6 Egypt Oncology-Cancer Drugs Market, By Types |
6.1 Egypt Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 Egypt Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 Egypt Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 Egypt Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Egypt Oncology-Cancer Drugs Market Export to Major Countries |
7.2 Egypt Oncology-Cancer Drugs Market Imports from Major Countries |
8 Egypt Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Survival rates of cancer patients in Egypt |
8.2 Adoption rate of innovative cancer therapies in the market |
8.3 Number of clinical trials conducted for oncology drugs in Egypt |
9 Egypt Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 Egypt Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Egypt Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Egypt Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 Egypt Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Egypt Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here